Reminder to make a note!
$Werewolf Therapeutics(HOWL.US$ Werewolf Therapeutics Inc: Plans to Present Interim, First-in-Human Clinical Data From Ongoing Phase 1 Trial of Wtx-330 in Q2 of 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment